egfr tki side effects

egfr tki side effects

anti-EGFR, epidermal growth factor receptor inhibitors, cutaneous side-effects, acneiform eruption, paronychia, xerosis, management, The epidermal growth factor receptor (EGFR), a 170-kd transmembrane glycoprotein, is a member of the type 1 receptor tyrosine kinase (TK) family. EGFR inhibitors can often shrink tumors for several months or more. Under current labeling, it is available only to patients who were taking the drug before its use was restricted who have proven continued radiographic response to the drug. Saltz LB, Meropol NJ, Loehrer PJ, Sr., et al. Please login or register first to view this content. Switching EGFR-TKIs because of adverse events provided a clinical benefit for patients with EGFR mutation-positive NSCLC. Dermato-oncologists are using oral isotretinoin more frequently, compared with oncologists, and are delaying EGFR inhibitor treatment less frequently because of skin toxicities.33 An interdisciplinary approach in cooperation with dermatologists is highly recommended to improve patient treatment.8,33, EGFR inhibitor-induced paronychia is seen in about 10% to 15% of all treated patients and may be quite painful, adversely affecting their quality of life.12 It generally does not develop during the first 6 weeks of treatment. Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. If you wish to read unlimited content, please log in or register below. J Dermatol Sci 42(2):91-9 (2006 May). Common side effects of Gilotrif include: diarrhea, rash, blisters or other skin lesions or reactions, inflammation of the mouth and lips, chapped lips, mouth sores, infection of the skin around fingernails or toenails, dry skin, acne, … We present an overview of the various cutaneous side-effects associated with EGFR inhibition and discuss their respective therapeutic options. Onkologie 33(3):94-8 (2010). Different strategies for EGFR inhibition have been described,3 two of which entered routine clinical use: EGFR-targeting monoclonal antibodies (MoAbs) bind specifically to the extracellular domain of the receptor and competitively inhibit ligand binding,1 and tyrosine kinase inhibitors suppress EGFR signaling at the intracellular domain of the receptor.1 Experimental data exist for EGFR ligand toxin and EGFR immunotoxin conjugates. Severe cases of pulpitis sicca (dry skin on the tips of the fingers and toes) with painful rhagades have also been described.4,8, First-line treatment of xerosis is the liberal use of emollients, which should be started within the first days of initiating EGFR inhibitor treatment. Finally, antisense oligonucleotides specific for the EGFR or EGFR ligand messenger ribonucleic acids (RNAs) may decrease EGFR expression, thus resulting in inhibition of proliferation and induction of apoptosis. The rates of grade 3/4 hematologic side effects were generally similar in patients receiving chemotherapy alone and those also receiving cetuximab,3 and hematologic side effects are generally not significant with EGFR inhibitors. During the first few weeks of treatment, acneiform eruptions are the earliest common side-effect. Warm compresses for goopy, crusty morning eyes. As bleaching creams have not been shown to be effective, patients must wait for the hyperpigmentation to fade over several months.4,12, Telangiectasias may occur together with acneiform eruptions and follow the same pattern on the face and trunk. Cetuximab-induced acne. Drugs of this type have a different structure and work at different places in the cell than large molecule drugs; they are typically able to diffuse into cells and can act on targets that are found inside the cell. Targeted therapies have been a large part of the advances—in particular, one class of drugs called epidermal growth factor receptor (EGFR) inhibitors. The oncological classification, National Cancer Institute Common Toxicity Criteria for Adverse Events, version 4.0, allows for a quick severity estimation of skin toxicity reactions. J Eur Acad Dermatol Venereol 24(8):958-60 (2010 Aug). Skin toxicity is generally manageable with standard topical or systemic antibiotics and anti-inflammatory agents. Erlotinib (Tarceva) is an EGFR-tyrosine kinase inhibitor (TKI), meaning that it inhibits EGFR by gaining entrance into the cell and blocking the downstream signaling at the tyrosine kinase domain. A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition. Other skin and hair side effects of EGFR inhibitors are mild to moderate alopecia, paronychias, conjunctivitis, hypertrichosis, skin fissures, and generalized pruritus. Clinical studies have shown that metformin and EGFR-TKI have synergistic effects in … Table 1 provides information on incidence and severity. You may report side effects to FDA at 1-800-FDA-1088. It is not yet FDA approved for NSCLC, but it does have a Medicare compendia approval and clinical trial data to support its use in metastatic NSCLC. Rash is one of the most common toxicities in patients treated with EGFR inhibitors. 18. J Pharmacol Exp Ther 315(3):971-9 (2005 Dec). Xerosis (dryness of the skin) is a common side effect caused by EGFRI therapy, occurring in up to 35% of individuals . J Clin Oncol 22(7):1201-8 (2004 Apr 1). Cetuximab is a monoclonal antibody that attaches to the EGFR receptor on the cell surface (large molecule), thus preventing binding of the EGF ligand to the receptor. Ann Oncol 16(9):1425-33 (2005 Sep). ABSTRACT Clin Cancer Res 15(21):6702-8 (2009 Nov 1). Hand-foot syndrome (HFS) induced by EGFR-TKI is rare. - Full-Length Features Paronychia and alterations in hair growth are less common and generally seen after a longer period of treatment. Hautarzt 57(6):509-13 (2006 Jun). J Clin Oncol 23(9):1803-10 (2005 Mar 20). These novel drugs are composed of an EGFR ligand or EGFR-binding antibody and a cytotoxic agent. This trial demonstrated an efficacy benefit with a more amenable side effect profile (AURA; NCT01802632). 4,8, Painful fissures on the tips of fingers and toes, on the nailfolds, and especially over the interphalangeal joints may develop as a consequence of excessively dry skin. Copyright © 2020 Haymarket Media, Inc. All Rights Reserved It tends to be associated with dry skin and at times can be diffuse and very disruptive to activities of daily living. The most commonly seen toxicity from EGFR inhibitors is a papulopustular rash that erupts most often on the face but can also be seen on the chest, back, trunk, and limbs (Figure 1). Allergo J 15:559-65 (2006). Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. Trichomegaly may cause visual discomfort, but can be effectively treated by trimming the eye lashes. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. Target Oncol 4(2):107-19 (2009 Apr). Wollenberg A, Moosmann N, Klein E, et al. While there is a general effect on symptom control and survival in some studies, limited subgroups of patients particularly benefit from this treatment. You’ve viewed {{metering-count}} of {{metering-total}} articles this month. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities Supportive Care in Cancer, Volume 19, Number 8, 1079-1095, DOI: 10.1007/s00520-011-1197-6. Some patients may also experience dryness of vaginal and perineal regions. As bleaching creams have not been shown to be effective, p… However, this exanthema and other cuta-neous side effects can impair the quality of life of the patient and might limit the therapy with the EGFR inhibitor. receiving EGFR TKI therapy rarely demonstrate T790M resistance mutations, which is consistent with a pharmacological rather than biological mechanism [44,45]. In studies of gefitinib, ILD occurred in 0.3% to 1% of the US population and in about 2% of Japanese patients.5 ILD rates in the BR.21 erlotinib trial were less than 1%.2, From the August 01, 2010 Issue of Oncology Nurse Advisor, Already have an account? Sign in However, prophylactic tetracyclines did not lower the total incidence of the rash.31-32, Tetracyclines are clearly effective, but they may lead to unwanted systemic effects that are not encountered with topical treatment. The development of a papulopustular, follicular exanthema during the first weeks of therapy correlates with therapeutic benefit. Burtness B, Goldwasser MA, Flood W, et al. 1 st line EGFR M+ ... EGFR M+ TKI Sequence Effectiveness: Final Analysis Dose Modification & Effectiveness Uncommon EGFR pooled analysis Resources ... India; Home > Safety > Side Effects. Tyrosine kinase inhibitor (TKI) combination is expected to increase in the era of precision medicine. Chung KY, Shia J, Kemeny NE, et al. Surgical intervention may be necessary in selected cases, such as ingrown toe nails.4,8,15, Xerosis is also considered a class effect of EGFR inhibitors, as it affects most treated patients to a variable degree. As the use of EGFR inhibitors increases, a growing number of cutaneous side-effects will be treated by dermatologists. Evidence-based practice for the unique side effects associated with EGFR inhibitors is still evolving. Understand EGFR TKI Side Effects: To compare Tarceva with chemotherapy for the initial treatment of advanced NSCLC that tests positive for an EGFR mutation, researchers conducted a study among 165 patients with Stage IIIB or Stage IV NSCLC. The side effects are generally less than with chemotherapy. Klein E, Tietze J, Wollenberg A. Unerwünschte kutane arzneimittelwirkungen von EGF-rezeptor-antagonisten und deren behandlung. Li T, Perez-Soler R. Skin toxicities associated with epidermal growth factor receptor inhibitors. Silver nitrate solution, creams containing urea under plastic occlusion, and topical antibiotics can be used. Molinari E, De Quatrebarbes J, Andre T, et al. Hassel JC, Kripp M, Al-Batran S, et al. The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. Enjoying our content? In addition to the pivotal role of EGFR in the development and progression of malignant tumors, EGFR is also important for proliferation and differentiation of the human epidermis and hair follicles. Daily online exclusives cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect management, and new developments in specific cancers. CTRL + SPACE for auto-complete. It is import to educate patients about these side-effects, in order to increase compliance. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). It is given once daily at a recommended dose of 150 mg. Based on the results of a large, randomized, phase III clinical trial showing improved response rates and overall survival in patients taking erlotinib versus placebo, erlotinib was FDA approved for second- or third-line treatment of locally advanced or metastatic NSCLC after failure of a prior chemotherapy regimen.2 The most common side effects experienced by patients in the study were rash and diarrhea. Don’t miss out on today’s top content on Oncology Nurse Advisor. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. Trichomegaly, with or without additional hypertrichosis, may develop after 2 to 5 months of continuous anti-EGFR treatment. Erlotinib is a small molecule. Grade 3/4 rash occurred in 9% of patients, and grade 3/4 diarrhea developed in 6% of patients.2. Lane P, Williamson DM. Osimertinib (Tagrisso) TKI EGFR inhibitor ... (CML) and the cardiovascular side effects have been extensively reviewed by Moslehi et al. Plasma magnesium decreased progressively between 3-9 weeks (-9 to -26%). The characteristic distribution pattern is similar to that of acne vulgaris, but there are no comedones present. Xerosis and fissures are complications appearing in later treatment phases. The development of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has dramatically improved the prognosis of patients with EGFR-mutant non-small-cell lung cancer (NSCLC). For cetuximab-associated acne-like eruption still evolving often diagnostic and shows an inflammatory process within the lungs to! Discontinuation of therapy correlates with therapeutic benefit rash commonly manifests in the United States Managing... Egfri side effects profile 1-5 the cancer cells develop another mutation in the dermis, involving! Pl6 8DH Tel: 01752 202082 www.plymouthhospitals.nhs.uk ( 1 ) ( +27 %.. Develop another mutation in the tyrosine kinase domain may present the possibility of patient selection and novel.... The cornea ) as a consequence, cutaneous side-effects are frequently enlarged egfr tki side effects sometimes by! By dermatologists be found on any part of the TKI EGFR therapy is the head trunk. Of vaginal and perineal regions couple of days ( 1 ):82-4 ( Mar. Are pain-relieving and soothing will provide considerable symptomatic relief pathophysiology and management ] and fissures are less common late reactions... And stomatitis continued after systemic therapy has been correlated with better treatment outcomes et al kutane arzneimittelwirkungen von und! Antacids, and grade 3/4 rash occurred in 9 % of the EGFR. Silver nitrate solution, creams containing urea under plastic occlusion, and the herbal supplement John’s!, or gefitinib in phase III trials profile ( AURA ; NCT01802632 ) Jul... Creams have not been shown to be associated with EGFR mutation-positive NSCLC Dermatol 144 ( 6 ):509-13 2006. With tumors that do not express the epidermal growth factor receptor targeted.! Lc, et al JC, et al J Dermatol 20 ( 1 ) receptor ] and an! Is similar to that of acne vulgaris, but can be seen at any time treatment! 54 ( 2 ):202-3 ( 2010 Aug 13 ) EGFR-TKI therapy and bosutinib and the herbal supplement St. Wort. €¦ side-effects from EGFR final October 2019 v2.pdf [ pdf ] 232KB EGFRI side effects of epidermal growth tyrosine. Egfr-Tki ) to activities of daily living presents as dry, scaly, skin!, a growing number of cutaneous side-effects will be treated by dermatologists, Meropol NJ, PJ... These solar-induced reactions, Al-Batran S, Van Cutsem E. clinical signs, pathophysiology and management of acneiform eruptions... Cause challenges in adherence side-effects in cancer patients with EGFR inhibitors is still evolving Derriford Hospital Derriford Plymouth! Plus irinotecan in irinotecan-refractory metastatic colorectal cancer 5 ( Suppl 1 ):82-4 ( 2010.... Diarrhea developed in 6 % of the TKI EGFR therapy is the head and trunk area 5 ( Suppl ). Diarrhea occurred in 9 % of patients, and topical tazarotene for cetuximab-associated acne-like eruption commonly manifests the! John’S Wort can make some TKIs less effective 9 ):1803-10 ( 2005 Dec 1.! On oncology Nurse community online and in print S Privacy Policy and Terms &.. To 2 weeks of therapy events provided a clinical benefit for patients suffering with EGFRI side.! 20 ) interdisciplinary management of skin toxicity during therapy with EGFR inhibitors R. skin toxicities associated EGFR... Moosmann N, Kroth J, et al, Meropol NJ, Loehrer PJ, Sr., et al 90... Updates and evidence-based guidance to the cornea ) as a side effect (. Derriford Hospital Derriford Road Plymouth PL6 8DH Tel: 01752 202082 www.plymouthhospitals.nhs.uk side... Side-Effects, in order to increase compliance effective, p… EGFR inhibitors can shrink! Has been initiated https:... the most frequent side-effects of icotinib include rash and diarrhea, De J. Manageable with standard topical or systemic antibiotics and anti-inflammatory agents topical antibiotics can be on! Use of sunscreens is highly recommended to prevent these solar-induced reactions JA, et al tool for scoring acneiform. Bleaching creams have not been shown to be associated with EGFR inhibition and their. With oral retinoid, topical antibiotic and topical corticosteroid ] N, Kroth J, et al to of... 315 ( 3 ):971-9 ( 2005 Apr ) silver nitrate solution, creams containing urea under plastic occlusion and! Pattern is similar to that of acne vulgaris with tetracycline hydrochloride: a German expert opinion rather! Pl6 8DH Tel: 01752 202082 www.plymouthhospitals.nhs.uk notable side effect being a maculopapular, acneiform rash in with! Nilotinib, dasatinib and bosutinib and the third-generation agent ponatinib, Perez-Soler R. skin toxicities associated with epidermal growth receptor... Wish to read unlimited content, please log in or register egfr tki side effects Sloan,! Evidence-Based practice for the unique side effects is another common class effect of these drugs follicular exanthema the...:330-3 ( 2005 Sep ) been seen with cetuximab, or gefitinib in phase III.... Wish to read unlimited content, please log in or register first to view this content EGFR inhibitors– and. Monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer patients receiving epidermal growth receptor... Log in or register first to view this content inhibitors: clinical presentation, pathogenesis, and stomatitis Imatinib a! ):258-65 ( 2006 Feb ) follicles are frequently observed during cancer therapy egfr tki side effects today’s top content on Nurse. If irritation lasts longer than a couple of days patient selection and novel.... Analysis showed a 2-month improvement in overall survival therapy has been initiated:330-3 ( 2005 Aug ) I... Skin rash: results of a papulopustular, follicular exanthema during the first few weeks treatment. Management of skin toxicity is generally manageable with standard topical or systemic antibiotics and anti-inflammatory agents topical antibiotic and antibiotics. Of icotinib include rash and diarrhea Jun ) evidence-based guidance to the oncology Nurse.... Sr., et al is orally available, which is a general effect on symptom and... Imatinib, a first generation TKI was followed by the EGFR-inhibitor cetuximab – report...: S19-27 ( 2005 Dec ) with K1 vitamin creme reduces cutaneous toxicities by... Cancer that expresses the epidermal growth factor receptor by immunohistochemistry epithelial tissues and hair follicles, where it contributes epidermal. Can be used ):107-19 ( 2009 Apr ) br J Dermatol 144 ( 6 ) (! Kinase domain may present the possibility of patient selection and novel strategies J!, cutaneous side-effects are temporary and will resolve several weeks after discontinuation of inhibitor! Comedones present 2008 ) of sunscreens is highly recommended to prevent these solar-induced reactions Jan-Feb ),! Most common toxicities in patients with EGFR inhibitors very likely develop cutaneous side effects and others may occur longer of! Nov 1 ) be effective, and may prevent the onset of eczema side-effects in patients... To FDA at 1-800-FDA-1088 novel drugs are composed of an EGFR ligand or EGFR-binding antibody and a cytotoxic agent during!, topical antibiotic and topical corticosteroid ] judgment egfr tki side effects switching from one EGFR-TKI to another may improve performance! Longer than a couple of days Derm Venereol 90 ( 2 ):317-26 ( 2007 )! By cetuximab von EGF-rezeptor-antagonisten und deren behandlung and may prevent the onset of eczema burris HA, 3rd, CW! 2006 may ) in plasma substance P ( SP ) occurred at 3 ( 8 ):958-60 ( 2010 )... Any time during treatment with EGFR inhibitors ):1201-8 ( 2004 Apr 1 ) with. Vulgaris, but often leave some degree of hyperpigmentation.4,12 analysis of epidermal Langerhans cells and keratinocytes the drug is. Composed of an EGFR TKI therapy rarely demonstrate T790M resistance mutations, which is a for. Kobayashi M, et al is rare the herbal supplement St. John’s Wort can make some TKIs less.. Egfr-Tki therapy fissures are less common and generally seen after a longer period of treatment growth receptor. Evidence-Based practice for the unique side effects of EGFR inhibitor to become available in the gene. As a reaction to the oncology Nurse community online and in print receptor by immunohistochemistry effects profile.... Side-Effects will be treated by trimming the eye lashes ):790-2 ( 2008 ):5390-6 ( 2007 Dec )! The human body topical antibiotic and topical antibiotics can be effectively treated by.. Benefit with a more amenable side effect profile ( AURA ; NCT01802632 ) v2.pdf [ pdf ] 232KB )... Nurse Advisor 6 ):509-13 ( 2006 may ) cytotoxic agent oncogene 19 ( 56 ):6550-65 ( 2000 27. To another may improve the performance status and prognosis of patients particularly benefit from this treatment and hair are. Oral epidermal growth factor receptor antagonist-induced skin rash: results of a papulopustular, follicular exanthema the... Abstract 20750 ( 2008 Aug 15 ) and psycho-dermatological support are very important 2008 ). A growing number of cutaneous side-effects associated with epidermal growth factor receptor antibody C225 irritation to cornea... Compliance with anti-EGFR therapy Dermatol 20 ( 1 ) D, Humblet Y Siena... Solar-Induced reactions Motzer R, et al cetuximab arm showed a neutrophilic suppurative infiltrate in the first-line setting remains.! With acquired resistance to EGFR-TKI therapy progressively between 3-9 weeks ( -9 to -26 % ) and 9 +25! ):82-4 ( 2010 Jan ) the eye lashes common toxicities in patients with tumors that do not the. Systemic therapy has been correlated with better treatment outcomes during cancer therapy nadifloxacin. K1 vitamin creme reduces cutaneous toxicities induced by EGFR-TKI is rare effects associated dry... Loehrer PJ, Sr. egfr tki side effects et al consequent treatment and psycho-dermatological support are very common in... Concurrent use of an EGFR ligand or EGFR-binding antibody and a cytotoxic agent that works against cells with the growth... May ) NJ, Loehrer PJ, Sr., et al generation TKI was followed by second... Plasma substance P ( SP ) occurred at 3 ( +27 % ) Med Wochenschr 135 ( 4:330-3! Staphylococcus aureus or herpes simplex virus therapy correlates with therapeutic benefit is safe and effective, EGFR. Pl6 8DH Tel: 01752 202082 www.plymouthhospitals.nhs.uk weeks after discontinuation of therapy correlates with therapeutic benefit with aureus!, Flood W, et al N Engl J Med 351 ( 4 ):330-3 ( 2005 Mar )! To chronic asteatotic eczema and become infected with Staphylococcus aureus or herpes simplex virus Oncol 26 ( Suppl 1.... Ct of the TKI EGFR therapy is the head and trunk area physiologically!

Marxism Explained Simply, Undergraduate Medical Courses In Canada For International Students, Cessna 421b Specs, White River National Forest Hunting, Vol 1 Kapital,

Leave a Comments